lung adenocarcinoma
Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
Expression of <span class="gene" id="21327329-0-14-59">xeroderma pigmentosum complementation group C</span> protein predicts cisplatin resistance in <span class="disease" id="21327329-0-101-120">lung adenocarcinoma</span> patients.